Facially Amphiphilic Polymers And Oligomers And Uses Thereof

Abstract

The present invention discloses methods of use of facially amphiphilic polymers and oligomers, including pharmaceutical uses of the polymers and oligomers as antimicrobial agents and antidotes for hemorrhagic complications associated with heparin therapy. The present invention also discloses novel facially amphiphilic polymers and oligomers and their compositions, including pharmaceutical compositions. The present invention further discloses the design and synthesis of facially amphiphilic polymers and oligomers.


Claims
IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jan 26, 2016
  • Application: Mar 17, 2004
    US US 80195104 A
  • Priority: Mar 17, 2004
    US US 80195104 A
  • Priority: Jan 20, 2004
    US US 53698004 P
  • Priority: Dec 19, 2003
    US US 53063003 P
  • Priority: Mar 17, 2003
    US US 45547903 P

Download Citation


Sign in to the Lens

Feedback